The Federal Trade Commission in October brought its  long-anticipated  lawsuit against the nation’s three biggest ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...